Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Talanta. 2024 Oct 1;278:126491. doi: 10.1016/j.talanta.2024.126491. Epub 2024 Jun 29.
To date, clinical laboratories face challenges in quantifying retinol from DBS samples. Disputes arise throughout the whole detection process, encompassing the storage condition, the release strategy as well as the selection of internal standards.
We incubated DBS with ascorbic acid solution. Then, retinol-d4 in acetonitrile was introduced to incorporate isotopic internal standard and promote protein precipitation. Afterward, sodium carbonate solution was added to ionize cytochromes (such as bilirubin), which amplified the difference of their hydrophobicity to retinol. Subsequently, cold-induced phase separation could be facilitated to separate retinol from the impurities. In the end, the upper layer was injected for LC-MS/MS analysis.
By comparing the detected retinol content in whole blood and DBS samples prepared from the same volume, we confirmed the established pretreatment was capable to extract most of retinol from DBS (recovery >90 %). Thereafter, we verified that within DBS, retinol possessed satisfying stability without antioxidation. Indoor-light exposure and storage duration would not cause obvious degradation (<10 %). Following systematic validation, the established method well met the criteria outlined in the relevant guidelines. After comparing with detected DBS results to the paired plasma samples, 54 out of 60 met the acceptance limit for cross-validation of ±20 %.
We realized precise quantification of retinol from one 3.2 mm DBS disc. By circumventing conventional antioxidation, liquid-liquid/solid-phase extraction and organic solvent evaporation, the pretreatment could be completed within 15 min consuming only minimal amounts of low-toxicity chemicals (ascorbic acid, acetonitrile, and sodium carbonate). We expect this contribution holds the potential to significantly facilitate the evaluation of patients' vitamin A status by using DBS samples in the future.
迄今为止,临床实验室在从 DBS 样本中定量测定视黄醇方面面临挑战。在整个检测过程中都会存在争议,包括储存条件、释放策略以及内标物的选择。
我们用抗坏血酸溶液孵育 DBS,然后加入视黄醇-d4 的乙腈溶液,引入同位素内标物,促进蛋白质沉淀。之后,加入碳酸钠溶液使细胞色素(如胆红素)离子化,从而放大其疏水性与视黄醇的差异。随后,可促进冷诱导相分离,将视黄醇与杂质分离。最后,注入上层液进行 LC-MS/MS 分析。
通过比较从相同体积全血和 DBS 样本中检测到的视黄醇含量,我们证实了所建立的预处理方法能够从 DBS 中提取大部分视黄醇(回收率>90%)。之后,我们验证了在 DBS 中,视黄醇无需抗氧化即可保持稳定。室内光照暴露和储存时间不会导致明显降解(<10%)。经过系统验证,所建立的方法完全符合相关指南中规定的标准。与配对的血浆样本相比,60 个 DBS 样本中有 54 个符合交叉验证的可接受限(±20%)。
我们实现了从一个 3.2mm 的 DBS 圆盘上精确定量视黄醇。通过绕过传统的抗氧化、液-液/固-液萃取和有机溶剂蒸发,预处理可以在 15 分钟内完成,仅消耗少量低毒性化学物质(抗坏血酸、乙腈和碳酸钠)。我们期望这一贡献有助于未来使用 DBS 样本更方便地评估患者的维生素 A 状态。